Is Repligen Corporation overvalued?

Repligen Corporation (RGEN) — key valuation metrics and fundamentals.

No verdict

Price

$189.68

Fair value

—

Current P/E

—

Normal P/E

37.9

Market cap

$10.70B

Dividend yield

0.0%

Return on equity

2.0%

Sector

Healthcare

Fair value compares RGEN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks